These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7237469)
1. Radiometric enzyme-inhibition technique for measuring acivicin in plasma. Jayaram HN; Kensler TW; Ardalan B Cancer Treat Rep; 1981; 65(5-6):491-4. PubMed ID: 7237469 [TBL] [Abstract][Full Text] [Related]
2. An enzymatic technique for measuring N-phosphonacetyl-L-aspartic acid in tissues. Cooney DA; Karlowicz MG; Cubillan J; Roettger M; Jayaram HN Cancer Treat Rep; 1978 Oct; 62(10):1503-7. PubMed ID: 361225 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin). Jayaram HN; Ardalan B; Deas M; Johnson RK Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase. Rosenfeld H; Roberts J Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials. McGovren JP; Pratt EA; Belt RJ; Taylor SA; Benjamin RS; Ardalan B; Ohnuma T Cancer Res; 1985 Sep; 45(9):4460-3. PubMed ID: 3896481 [TBL] [Abstract][Full Text] [Related]
6. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma. Denton JE; Lui MS; Aoki T; Sebolt J; Weber G Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346 [TBL] [Abstract][Full Text] [Related]
7. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis. Kensler TW; Jayaram HN; Cooney DA Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804 [TBL] [Abstract][Full Text] [Related]
8. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma. Aoki T; Sebolt J; Weber G Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374 [TBL] [Abstract][Full Text] [Related]
9. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma. Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920 [TBL] [Abstract][Full Text] [Related]
10. Acivicin inhibits Crithidia fasciculata growth in a serum-free medium and inactivates carbamoyl-phosphate synthetase II in vivo. Aoki T; Oya H Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):391-6. PubMed ID: 2902999 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of Crithidia fasciculata carbamoyl phosphate synthetase II by the antitumor drug acivicin. Aoki T; Oya H Mol Biochem Parasitol; 1987 Mar; 23(2):173-81. PubMed ID: 3574357 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma. Kensler TW; Reck LJ; Cooney DA Cancer Res; 1981 Mar; 41(3):905-9. PubMed ID: 7459876 [No Abstract] [Full Text] [Related]
13. Carbamyl phosphate synthetase III, an evolutionary intermediate in the transition between glutamine-dependent and ammonia-dependent carbamyl phosphate synthetases. Hong J; Salo WL; Lusty CJ; Anderson PM J Mol Biol; 1994 Oct; 243(1):131-40. PubMed ID: 7932737 [TBL] [Abstract][Full Text] [Related]
14. The glutamine analog acivicin as antipyrimidine. Studies on the interrelationship between pyrimidine and urea synthesis in liver. Pausch J; Rasenack J; Häussinger D; Holstege A; Gerok W Adv Enzyme Regul; 1985; 24():233-43. PubMed ID: 3835821 [TBL] [Abstract][Full Text] [Related]
15. Role of the hinge loop linking the N- and C-terminal domains of the amidotransferase subunit of carbamoyl phosphate synthetase. Huang X; Raushel FM Arch Biochem Biophys; 2000 Aug; 380(1):174-80. PubMed ID: 10900147 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501). Meck RA; Clubb KJ; Allen LM; Yunis AA Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid. Loh E; Kufe DW Cancer Res; 1981 Sep; 41(9 Pt 1):3419-23. PubMed ID: 7260907 [TBL] [Abstract][Full Text] [Related]
18. Biochemical pharmacology of acivicin in rat hepatoma cells. Lui MS; Kizaki H; Weber G Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366 [TBL] [Abstract][Full Text] [Related]
19. Acivicin. An antitumor antibiotic. Poster DS; Bruno S; Penta J; Neil GL; McGovren JP Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of the amidotransferase activity of carbamoyl phosphate synthetase by the antibiotic acivicin. Miles BW; Thoden JB; Holden HM; Raushel FM J Biol Chem; 2002 Feb; 277(6):4368-73. PubMed ID: 11729189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]